Alexion develops key treatments for rare disorders, which improves the lives of patients.
Alexion is poised to achieve double-digit increases in revenue and earnings as there is not much competition for the indications that the company addresses.
The reasonable valuation and above-average growth will drive strong stock gains.
When you're feeling like investing with your conscience, a company like Alexion Pharmaceuticals (ALXN) can give you that warm and fuzzy feeling. Alexion develops treatments for rare diseases where no other treatment is